Works matching IS 14642662 AND DT 2018 AND VI 19 AND IP 2


Results: 14
    1
    2
    3
    4
    5
    6
    7
    8

    Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens.

    Published in:
    HIV Medicine, 2018, v. 19, n. 2, p. 102, doi. 10.1111/hiv.12557
    By:
    • the EuroSIDA Study Group;
    • Cozzi‐Lepri, A.;
    • Mocroft, A.;
    • Yust, I.;
    • Schmid, P.;
    • Gottfredsson, M.;
    • Khromova, I.;
    • Jilich, D.;
    • Flisiak, R.;
    • Smidt, J.;
    • Rozentale, B.;
    • Radoi, R.;
    • Zangerle, R.;
    • Losso, M. H.;
    • Machala, L.;
    • Zilmer, K.;
    • Ristola, M.;
    • Pradier, C.;
    • Kirk, O.;
    • Lundgren, J. D.
    Publication type:
    Article
    9

    Issue Information.

    Published in:
    HIV Medicine, 2018, v. 19, n. 2, p. 1, doi. 10.1111/hiv.12548
    Publication type:
    Article
    10
    11
    12
    13
    14